SELECTBIO - The Space Summit 2019 Biographies

Home

Agenda

Keynote Speakers

Registration

Exhibition

Venue

Training Courses

Co-Located Conferences

Neurodegenerative Disease Research on the International Space Station

Monday, 14 October 2019 at 17:15

Add to Calendar ▼2019-10-14 17:15:002019-10-14 18:15:00Europe/LondonNeurodegenerative Disease Research on the International Space StationThe Space Summit 2019 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

The ability to create pluripotent stem cells from adult cells has created a new tool to study human diseases. We are studying neurons from Parkinson’s patients and neurons from patients with multiple sclerosis on the International Space Station using a 3D culture model to better understand mechanisms of neurodegeneration.

Andres Bratt-Leal, Vice President, Research and Development, Aspen Neuroscience

Andres Bratt-Leal co-founded Aspen Neuroscience with Jeanne Loring, a company focused on developing autologous cell therapies for neurological diseases. Dr. Bratt-Leal received his Ph.D. in Biomedical Engineering from Georgia Tech and Emory University.